目次

Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

List of Tables
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests
Spain
Adenovirus Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Influenza Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Influenza Testing Market Diagnostics Sales
by Major Supplier
Spain
Legionella Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Mononucleosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Mononucleosis Testing Market Diagnostics Sales
by Major Supplier
Spain
Mycoplasma Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Mycoplasma Testing Market Diagnostics Sales
by Major Supplier
Spain
Pneumonia Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
RSV Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
RSV Testing Market Diagnostics Sales
by Major Supplier
Spain
Tuberculosis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Tuberculosis Testing Market Diagnostics Sales
by Major Supplier